This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Initiator Pharma 미래 성장

21.5%

수익 성장률

25.7%

EPS 성장률

업데이트 없음

수익 및 매출 성장 예측

OM:INIT BTA - 애널리스트의 미래 추정치 및 과거 재무 데이터 (DKK Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2024	33	-37	-39	-39	1
12/31/2023	106	44	51	51	1
12/31/2022	N/A	-46	-36	-36	1
3/31/2022	N/A	-34	-40	-40	N/A
12/31/2021	N/A	-21	-34	-34	N/A
9/30/2021	N/A	-16	-29	-29	N/A
6/30/2021	N/A	-10	-11	-11	N/A
3/31/2021	N/A	-8	-10	-10	N/A
12/31/2020	N/A	-9	-8	-8	N/A
9/30/2020	N/A	-10	-8	-8	N/A
6/30/2020	N/A	-9	-7	-7	N/A
3/31/2020	N/A	-9	-8	-8	N/A
12/31/2019	N/A	-8	-9	-9	N/A
9/30/2019	N/A	-7	-7	-7	N/A
6/30/2019	N/A	-9	-7	-7	N/A
3/31/2019	N/A	-8	-10	-10	N/A
12/31/2018	N/A	-10	-14	-14	N/A
9/30/2018	N/A	-13	-16	-16	N/A
6/30/2018	N/A	-11	-14	-14	N/A
3/31/2018	N/A	-10	-11	-11	N/A
12/31/2017	N/A	-9	-8	-8	N/A
9/30/2017	N/A	-7	-4	-4	N/A

수입 대 저축률: INIT BTA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.4%).

수익 vs 시장: INIT BTA is forecast to become profitable over the next 3 years, which is considered above average market growth.

고성장 수익: INIT BTA is expected to become profitable in the next 3 years.

수익 대 시장: INIT BTA's revenue (62.7% per year) is forecast to grow faster than the Swedish market (9.4% per year).

고성장 수익: INIT BTA's revenue (62.7% per year) is forecast to grow faster than 20% per year.

미래 ROE: Insufficient data to determine if INIT BTA's Return on Equity is forecast to be high in 3 years time